TVGN logo

Tevogen Bio Holdings (TVGN)

Profile

Full Name

Tevogen Bio Holdings Inc.

Ticker Symbol

TVGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 5, 2022

Indexes

Not included

Website

http://tevogen.com

Employees

18

Key Details

Price

$1.08(+8.00%)

Market cap

$198.60M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.07(+81.70% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.08
TVGN price is $1.08

30-Day Relative Volume

1.21
TVGN 30-day relative volume is 1.21

Price Performance

Price Most recent change

+8%
TVGN price was up +8% on Apr 11, 2025

Price YTD change

+4.85%
TVGN price is up +4.85% since January 1st

Price 1-year change

-56.28%
TVGN price is down -56.28% year-on-year

Price 3-year change

-89.2%
TVGN price is down -89.2% over the past 3 years

Price Range

Price All-time high

$21.09
TVGN price is currently -94.88% below its historical high of $21.09

Price 3-year low

$0.26
TVGN price is currently +321.88% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$198.60M
TVGN market capitalization is $198.60 million

Market cap 3-year change

-
TVGN market capitalization 3-year change is unknown

Market cap All-time high

$1.79B
TVGN market capitalization is currently -88.93% below its historical high of $1.79 billion

Market cap sector rank

57.68%
TVGN market capitalization is higher than 57.68% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+11.71%
TVGN shares outstanding is up +11.71% year-on-year

Shares Outstanding 3-Year Change

-
TVGN shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.29
TVGN beta is 1.29

200-day SMA

$1.06
TVGN price is currently +2.21% above its 200-day simple moving average

50-day SMA

$1.26
TVGN price is currently -13.98% below its 50-day simple moving average

RSI

46.95
TVGN 14-day relative strength index is 46.95

Volume

1.21
TVGN 30-day relative volume is 1.21

ATR

$0.12
TVGN average true range is $0.12

10-day Historical Volatility

134.85%
TVGN 10-day historical volatility is 134.85%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TVGN annual revenue value is unknown

Revenue Analysts estimate

-
TVGN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TVGN annual revenue 1-year change is unknown

Revenue Sector rank

-
TVGN annual revenue is unknown

EPS

EPS

-$0.07
TVGN annual earnings per share is -$0.07

EPS Analysts estimate

-
TVGN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+81.7%
TVGN annual earnings per share is up +81.7% year-on-year

EPS Sector rank

81.17%
TVGN annual earnings per share is higher than 81.17% of companies in Healthcare sector

Profit

Gross profit

-
TVGN annual gross profit value is unknown

Gross margin

-
TVGN annual gross profit margin value is unknown

Operating profit

-$53.56M
TVGN annual operating income is -$53.56 million

Operating margin

-
TVGN annual operating profit margin value is unknown

Net income

-$13.73M
TVGN annual net profit is -$13.73 million

Net margin

-
TVGN annual net profit margin value is unknown

Expenses

Total expenses

$53.56M
TVGN annual total expenses is $53.56 million

Operating expenses

$53.56M
TVGN annual total operating expenses is $53.56 million

Cost of goods sold

-
TVGN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$22.53M
TVGN annual SGA is $22.53 million

Depreciation and amortization

$403.60K
TVGN annual depreciation & amortization is $403.60 thousand

Interest expense

$184.00K
TVGN annual interest expense is $184.00 thousand

Income tax

-
TVGN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$13.54M
TVGN annual earnings before interest & taxes is -$13.54 million

EBITDA

-$13.14M
TVGN annual EBITDA is -$13.14 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.46M
TVGN annual total assets is $3.46 million

Non current assets

$1.10M
TVGN annual long term assets is $1.10 million

Current assets

$2.36M
TVGN annual total current assets is $2.36 million

Cash and cash equivalents

$1.28M
TVGN annual cash & cash equivalents is $1.28 million

Accounts receivable

-
TVGN annual accounts receivable value is unknown

Inventory

-
TVGN annual inventory value is unknown

Liabilities

Total liabilities

$10.14M
TVGN annual total liabilities is $10.14 million

Long term liabilities

$1.09M
TVGN annual total long term liabilities is $1.09 million

Current liabilities

$9.04M
TVGN annual total current liabilities is $9.04 million

Accounts payable

$5.20M
TVGN annual accounts payable is $5.20 million

Debt

Total debt

$2.89M
TVGN annual total debt is $2.89 million

Total debt 1-year change

-96.98%
TVGN annual total debt is down -96.98% year-on-year

Long term debt

$1.01M
TVGN annual long term debt is $1.01 million

Short term debt

$1.88M
TVGN annual short term debt is $1.88 million

Equity & Capital

Shareholders equity

-$6.67M
TVGN annual stockholders equity is -$6.67 million

Book value

-$15.47M
TVGN annual book value is -$15.47 million

Retained earnings

-$113.39M
TVGN annual retained earnings is -$113.39 million

Working capital

-$6.68M
TVGN annual working capital is -$6.68 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.00M
TVGN annual cash flow from operations is -$12.00 million

Cash from operations 1-year change

-46.84%
TVGN annual cash flow from operations is down -46.84% year-on-year

Cash from investing

$0.00
TVGN annual cash flow from investing activities is $0.00

Cash from investing 1-year change

+100%
TVGN annual cash flow from investing activities is up +100% year-on-year

Cash from financing

$12.23M
TVGN annual cash flow from financing activities is $12.23 million

Cash from financing 1-year change

+215.81%
TVGN annual cash flow from financing activities is up +215.81% year-on-year

CAPEX

CAPEX

-
TVGN annual capital expenditures value is unknown

CAPEX 1-year change

-
TVGN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.00M
TVGN annual free cash flow is -$12.00 million

Free cash flow 1-year change

-44.49%
TVGN annual free cash flow is down -44.49% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TVGN annual gross profit margin value is unknown

Operating margin

-
TVGN annual operating profit margin value is unknown

Net margin

-
TVGN annual net profit margin value is unknown

ROA & ROE

ROA

-396.55%
TVGN annual return on assets is -396.55%

ROE

205.68%
TVGN annual return on equity is 205.68%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TVGN price to earnings ratio value is unknown

PE ratio Sector rank

-
TVGN price to earnings ratio is unknown

PB Ratio

PB ratio

-12.83
TVGN price to book ratio is -12.83

PB ratio Sector rank

2.3%
TVGN price to book ratio is higher than 2.3% of companies in Healthcare sector

PS Ratio

PS ratio

-
TVGN price to sales ratio value is unknown

PS ratio Sector rank

-
TVGN price to sales ratio is unknown

Enterprise value

Enterprise value

$200.21M
TVGN enterprise value is $200.21 million

Enterprise value Sector rank

59.45%
TVGN enterprise value is higher than 59.45% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-16.52
TVGN EV/EBITDA is -16.52

EV/EBITDA Sector rank

7.04%
TVGN EV/EBITDA is higher than 7.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.26
TVGN annual current ratio is 0.26

Quick ratio

-
TVGN annual quick ratio value is unknown

Leverage

Debt to equity

-0.43
TVGN annual debt to equity ratio is -0.43

Interest coverage ratio

-73.60
TVGN annual interest coverage ratio is -73.60

Risk & Stability

Piotroski F-Score

-
TVGN piotroski f-score value is unknown

Altman Z-Score

-
TVGN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 11, 25 D. Boral Capital
Buy
Mar 4, 25 D. Boral Capital
Buy

Institutional Ownership

Similar stocks

CDTX logo
Cidara Therapeutics (CDTX)
DBVT logo
DBV Technologies SA (DBVT)
Performant Healthcare (PHLT)
CARGO Therapeutics (CRGX)
OCGN logo
Ocugen (OCGN)
QTRX logo
Quanterix (QTRX)
ESPR logo
Esperion Therapeutics (ESPR)
CDXS logo
Codexis (CDXS)
NVCT logo
Nuvectis Pharma (NVCT)
  • What is the ticker symbol for Tevogen Bio Holdings?
  • Does Tevogen Bio Holdings pay dividends?
  • What sector is Tevogen Bio Holdings in?
  • What industry is Tevogen Bio Holdings in?
  • What country is Tevogen Bio Holdings based in?
  • When did Tevogen Bio Holdings go public?
  • Is Tevogen Bio Holdings in the S&P 500?
  • Is Tevogen Bio Holdings in the NASDAQ 100?
  • Is Tevogen Bio Holdings in the Dow Jones?
  • When was Tevogen Bio Holdings's last earnings report?
  • When does Tevogen Bio Holdings report earnings?
  • Should I buy Tevogen Bio Holdings stock now?

What is the ticker symbol for Tevogen Bio Holdings?

The ticker symbol for Tevogen Bio Holdings is NASDAQ:TVGN

Does Tevogen Bio Holdings pay dividends?

No, Tevogen Bio Holdings does not pay dividends

What sector is Tevogen Bio Holdings in?

Tevogen Bio Holdings is in the Healthcare sector

What industry is Tevogen Bio Holdings in?

Tevogen Bio Holdings is in the Biotechnology industry

What country is Tevogen Bio Holdings based in?

Tevogen Bio Holdings is headquartered in United States

When did Tevogen Bio Holdings go public?

Tevogen Bio Holdings's initial public offering (IPO) was on January 5, 2022

Is Tevogen Bio Holdings in the S&P 500?

No, Tevogen Bio Holdings is not included in the S&P 500 index

Is Tevogen Bio Holdings in the NASDAQ 100?

No, Tevogen Bio Holdings is not included in the NASDAQ 100 index

Is Tevogen Bio Holdings in the Dow Jones?

No, Tevogen Bio Holdings is not included in the Dow Jones index

When was Tevogen Bio Holdings's last earnings report?

Tevogen Bio Holdings's most recent earnings report was on Nov 19, 2024

When does Tevogen Bio Holdings report earnings?

The next expected earnings date for Tevogen Bio Holdings is May 30, 2025

Should I buy Tevogen Bio Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page